ISSN:

Journal Home

Journal Guideline

Clinical Neuropharmacology Q3 Unclaimed

Lippincott Williams and Wilkins United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Neuropharmacology is a journal indexed in SJR in Pharmacology and Neurology (clinical) with an H index of 87. It has a price of 2395 €. It has an SJR impact factor of 0,326 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,326.

Clinical Neuropharmacology focuses its scope in these topics and keywords: treatment, patients, sleep, advanced, angiotensinconverting, attacks, autism, bruxisma, cancerrestless, combination, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (clinical) (Q3) Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,326

SJR Impact factor

87

H Index

42

Total Docs (Last Year)

151

Total Docs (3 years)

1144

Total Refs

172

Total Cites (3 years)

145

Citable Docs (3 years)

1.45

Cites/Doc (2 years)

27.24

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Clinical Pharmacy and Therapeutics Q3
Anti-Cancer Agents in Medicinal Chemistry Q3
Psychopharmacology Bulletin Q3
Korean Journal of Physiology and Pharmacology Q3
Anti-Cancer Drugs Q3

Compare this journals